Wednesday, 26 August 2026European Markets

AZERION Stock Bearish By 30% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of AZERION (AEX-Index: AZRN.AS) fell by a staggering 30.17% in 21 sessions from 4.74 € to 3.31 € at 01:09 EST on Thursday, after two successive sessions in a row of losses. AEX-Index is sliding 0.62% to 748.40 €, following the last session's upward trend.

About AZERION

Azerion Group N.V. operates a digital entertainment and media platform worldwide. Its integrated platform provides technology solutions to automate the purchase and sale of digital advertising inventory for advertisers, publishers, and game creators, as well as to develop, publish, distribute, and operate online social and casual games, and digital content. The company was founded in 2014 and is headquartered in Schiphol-Rijk, the Netherlands. Azerion Group N.V. is a subsidiary of Principion Holding B.V.

Earnings Per Share

As for profitability, AZERION has a trailing twelve months EPS of -167 €.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AZERION's stock is considered to be overbought (>=80).

More news about AZERION (AZRN.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com